MKI67 and cervical carcinoma: However, given the relatively weak association with cervical cancer, a combination with other biomarkers, such as E6/E7 mRNA, p16INK4a-Ki-67, and HPV integration [30, 31], may improve the prediction of cervical cancer risk for HPV-positive women.